Very bad company culture - Mitarbeiter (anonym) bei Merck: Mitarbeiterbewertung

1,0
15. Mai 2014
Mitarbeiter (anonym)
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

- Good name to have on your resume. If you are taking a job at Merck these days, you better have thick skin because you will be disrespected everyday. Be careful of who you talk to because speaking your mind can get you fired. There will be no good work life balance - try to hold the job for about 2 years and in the mean time, have a job at another company lined up and hope you aren't laid off or fired in the mean time. - It used to be a good company that promoted research but sadly, that has gone away - Good pay and benefits, both of which are constantly being cut down

Kontras

- Research is being cut down and not much in the pipeline. Merck used to be known for investing in research but there is not much new research going on at the moment. These days, it is just combine this drug with another drug and make a new drug and make some money - Good employees are being let go to cut cost - The share price is all that matters to the people running the company, the CEO included - Employees are just numbers. People are being let go every month and the remaining people are expected to do the work of 3 or 4 other people without complaining. If you speak up, you either get fired or you get a bad review on your performance report - The environment currently promoted at Merck is for employees to stab each other in the back - the ones that are very good at this survive and get promoted

Mehr Bewertungen zu Merck entdecken

5,0
30. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Excellent company to work with.

Kontras

No cons encountered so far

4,0
30. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Kontras

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle